Skip to main content

Together we are beating cancer

Donate now

Cancer Research UK-funded research

Showing 12 out of 968 results
Wales lifting Six Nations trophy in 2019.

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage. During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

by Angharad Kolator Baldwin | Analysis | 27 August 2021

27 August 2021

  • Science & Technology
  • For Researchers

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

by Phil Prime | Research Feature | 28 July 2021

28 July 2021

Medical technologist holding urine tube test in medical laboratory

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma. Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

by Cancer Research UK | News | 23 July 2021

23 July 2021

Two people in a doctor's waiting room

A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic. A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.

by Cancer Research UK | News | 16 July 2021

16 July 2021

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible. A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

by Harry Jenkins | Analysis | 14 July 2021

14 July 2021

antibodies

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

by Cancer Research UK | Research Feature | 2 July 2021

2 July 2021

doctor holding urine sample

The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures. The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.

by Harry Jenkins | News | 2 July 2021

2 July 2021

Researcher in a lab

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment. A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

by Cancer Research UK | News | 28 June 2021

28 June 2021

Graphic explaining the IDx trial.

The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable. The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.

by Harry Jenkins | News | 16 June 2021

16 June 2021

White pills on a pink background

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery. Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

by Harry Jenkins | News | 26 May 2021

26 May 2021